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Edited by Frances ShannonAbstract The photochemical internalisation (PCI) technology
liberates endocytosed macromolecules like transgenes from
endocytic vesicles in response to photochemical treatment.
Thereby PCI improves gene transfection and is suggested for
use in gene therapy. It has been proposed that PCI might also
stimulate transcription of internalised transgenes, especially if
they are controlled by photochemically inducible promoters
(transcriptional targeting). In order to identify inducible promo-
ters, and to evaluate the treatments inﬂuence on cellular tran-
scriptional activity, the eﬀect of the photochemical treatment
as used in PCI (with the photosensitizer disulfonated meso-tetra-
phenylporphin followed by illumination) on gene transcription in
WiDr adenocarcinoma cells was evaluated using microarrays.
The expression of 390 genes were identiﬁed signiﬁcantly changed
(89% were up-regulated), of which genes associated with DNA
binding and transcriptional functions were the most represented.
This may be important for the expression of a photochemically
internalised transgene under a speciﬁc promoter control. Real-
time PCR veriﬁed photochemical up-regulation of the HSP
family genes, as well as down-regulation of EGR-1 at 2–10 h
post-treatment, suggesting that the HSP (particularly HSP70),
in addition to the microarray-identiﬁed metallothioneins, but
not the EGR-1 promoters, could be relevant promoter candidates
for transcriptional targeting via PCI. The resulting overview of
gene expression changes in WiDr cells exposed to the PCI-rele-
vant photochemical treatment also provide a basis for the design
of new PCI-based strategies with respect of transcriptional tar-
geting.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Most macromolecular drugs meant to act intracellular enter
cells via endocytosis, and are trapped in the endocytic vesicles,
from where they are unable to escape to perform a therapeutic
function. Liberation of such macromolecules into the cytosol
can be achieved by the photochemical disruption of the mem-
branes of the endocytic vesicles [1]. Use of endosome-localising
photosensitizers activated by illumination with visible light
(i.e. photochemical treatment) generates singlet oxygen, which
induces permeabilisation of the vesicular membranes. This
results in release of the vesicular content in photochemically
treated cells [2], but not in cells unexposed to light. This con-
cept has been named photochemical internalisation (PCI) [1]
and it is based on photosensitizers with photochemical proper-
ties similar to those utilized in photodynamic therapy (PDT) of
cancer. PCI has been successfully applied pre-clinically for
delivery of chemotherapeutic agents [3], protein toxins [4,5]
and peptide nucleic acids (PNA) [6], enhancing their anticancer
activity in vitro and in vivo at speciﬁc sites, i.e. photochemi-
cally treated tumors. In gene therapy, PCI has resulted in en-
hanced expression of foreign genes (transgenes) carried by
viral [7–9] and nonviral vectors [10–13]. Endosomal release
of the transgene is recognised to be the main reason for this
enhancement in PCI-treated cells [9,10]. However, recently it
has been proposed that PCI-treatment could stimulate also
transcription of the liberated transgene, especially if this trans-
gene is controlled by a photochemically inducible promoter
[14]. Such transcriptional targeting would enhance the speciﬁc-
ity of PCI-based gene therapy. The potential of this idea has
been tested employing a promoter of the Heat Shock Protein
gene HSP70 [14], known usually to be induced by various
stressors such as PDT [15]. Though PCI-dependent activation
of the HSP70 promoter-controlled transgene has been demon-
strated, the enhancement was moderate [14]. Therefore, a more
thorough analysis of the photochemical inﬂuence on a cellular
transcriptional apparatus and identiﬁcation of PCI-inducible
promoters was needed for a rational utilisation of PCI in tran-
scriptional targeting. Moreover, recently it has been shown
that the PCI eﬀect on transgene expression controlled by the
cytomegalovirus (CMV) promoter is more pronounced at the
mRNA level than at the protein level [9]. This suggests that
PCI might inﬂuence the transcription positively, and/or the
translation machinery of the cell negatively. So far, the cellularation of European Biochemical Societies.
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been little investigated, despite that the eﬃciency of PCI-based
therapies might be aﬀected by changes in diﬀerent cellular pro-
cesses. For example, PCI might modulate expression of genes
encoding proteins that are involved in transcription, transla-
tion and/or the function of the internalised transgene. There-
fore, characterisation of changes related to various cellular
functions is important for understanding and further develop-
ment of PCI-based strategies.
In the present study, we addressed the problem of the cellu-
lar response to the photochemical treatment as used in PCI by
proﬁling gene expression. To date very limited data on gen-
ome-wide transcriptional changes following photochemical
treatment are available. Most of these studies aimed to reveal
the molecular mechanisms of PDT-mediated cell killing, and
employed photosensitizers not relevant for PCI [16,17]. Since
the molecular response to photochemical treatment varies sig-
niﬁcantly depending on the photosensitizer’s localisation (i.e.
where singlet oxygen is generated) [18], for PCI purposes it
was of importance to characterise changes associated with
the PCI-relevant treatment, i.e. with a photosensitizer like
disulfonated meso-tetraphenylporphin (TPPS2a), localised to
the membranes of endocytic vesicles.
The aim of the present study was to identify genes that were
transcriptionally regulated by a PCI-relevant photochemical
treatment as detected using microarrays. This would lead to
the indentiﬁcation of the photochemically inducible promoters
that could be combined with PCI to mediate transcriptional
targeting. Also, this would indicate which cellular functions
are aﬀected following PCI.2. Materials and methods
2.1. Photochemical treatment
The human adenocarcinoma cell line WiDr (ATCC, CCL-218) was
cultured in RPMI-1640 medium supplemented with 10% fetal calf ser-
um (Sigma, MO, USA) at 37 C in a 5% CO2 atmosphere. For photo-
chemical treatment, the cells were incubated overnight in a medium
containing 0.7 lg/ml the photosensitizer TPPS2a (Frontier Scientiﬁc,
Logan, UT), chased for 4 h in TPPS2a-free medium and exposed to
blue light (LumiSource 4 * 18 W Osram L 18/67 Blue (PCI Biotech
AS, Norway)) with an irradiance of 11.7 mW/cm2. The light dose
was 0.7 J/cm2, which corresponded to 60 s illumination and led to a cell
survival of 50% (LD50) as measured by the MTT-assay one day after
the treatment.
2.2. RNA preparation and labeling for arrays
Total RNA was isolated 3 h after photochemical treatment using
Trizol Reagent (Invitrogen, Carlsbad, CA). The total RNA from con-
trol cells, not treated with the photosensitizer, but exposed only to blue
light, was used as a reference. cDNA was synthesized from 40 lg of
total RNA by an oligo(dT)-primed reverse transcriptase reaction and
labeled with Cy3 and Cy5 using an indirect aminoallyl FairPlaye
(Stratagene, La Jolla, CA) microarray labeling kit, according to the
manufacturer’s recommendations. Lucideae Universal ScoreCard
(Amersham Biosciences) spike mRNAs were added to the samples
prior to cDNA synthesis. Labeled Cy3- and Cy5-cDNA was up-con-
centrated to 10 ll using Microcon YM-30 columns (Amicon, Millipore
Corporation, Bedford, MA).
2.3. cDNA microarrays and hybridisations
The microarrays were produced in house using a Micro Grid II
robotic printer (Bio Robotics, Cambridge, UK). The targets (13.000
unique I.M.A.G.E. cDNA clones from ResGen 40 k set) were spotted
on aminosilane-coated UltraGAPS slides (Corning Life Sciences,
Corning, NY). For details on the arrays, we refer to: http://www.mikromatrise.no. The hybridization volume of 110 ll consisted of:
8–10 ll of each of the labelled probes, 16 lg poly A (Amersham Biosci-
ences), 15 lg human Cot-1 DNA (Invitrogen) and 85–90 ll of Micro-
array Hybridization Buﬀer #1 from Ambion (Austin, TX). The ﬁnal
mix was heated for 2 min at 100 C and after spinning applied to a
microarray. A hybridization station (Genomic Solutions, Inc., Ann
Arbor, MI) was used for hybridization and wash (the details can be
found in http://www.mikromatrise.no).2.4. Data preparation and analysis
The microarray slides were scanned using an Agilent Microarray
scanner (Agilent Biotechnologies, Palo Alto, CA). The image quanti-
ﬁcations were performed by the software GenePix 4000B
(Axon Instruments, Union City, CA). The DNA spots were cap-
tured by the adaptive circle segmentation method. The images
(TIFF ﬁles) and extracted raw data (GRP ﬁles) were stored in a
BASE 1.2.15 database. The spots that were technically ﬂawed or
ﬂagged automatically by the GenePix software, as well as spots with
a diameter less than 60 mm, were removed from the data of each
microarray. Background-subtracted intensities less than two times
the standard deviation (S.D.) of the local background in one channel
were assigned this value to avoid zero or negative values in the ratio
calculations. Weak spots with background-subtracted intensity
less than two times the S.D. of the local background in both chan-
nels were excluded. Systematic errors were corrected by normaliz-
ing the data, using the locally weighted scatterplot smoother
(LOWESS) procedure. The genes were preserved if the values were
experimentally obtained in three or more arrays in the experimental
matrix.
The signiﬁcantly altered genes were identiﬁed by Signiﬁcance Anal-
ysis of Microarrays (SAM) [19] by the use of the TIGR Multiexperi-
ment Viewer (MeV) (http://www.tm4.org/mev.html). For functional
classiﬁcation of the genes, UniProt Knowledgebase keywords (Release
50.4 of July 25, 2006) and the KEGG Pathway Database (July 19,
2006) were used. Functional classiﬁcation was performed by using
the Database for Annotation, Visualization and Integrated Discovery
(DAVID, release 2.1) [20] on line tools. The gene-enrichment of func-
tional categories was measured by determining the number of genes
belonging to the functional group in the list of modulated genes
weighed against the total number of analysed genes on arrays (back-
ground) through the use of the Fisher Exact test.2.5. Real-time PCR
Total RNA was isolated from the control cells (as in microarray
experiments) and from the photochemically treated cells at 2 h, 4 h
and 10 h post-treatment by the use of Trizol Reagent (Invitrogen).
The cDNA was synthesized from 1 lg DNase I-treated RNA using
the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). The cDNA
solution was diluted 1:3 or 1:6 with nuclease-free water. Real-time
PCR was performed using an iQ SYBR Green supermix (Bio-Rad)
and speciﬁc primer pairs for the selected genes (speciﬁed in Supplemen-
tary Table 1 and Fig. 2). Primers (speciﬁed in Supplementary Table 1)
were designed using the software Primer Express (Applied Biosystems,
Foster City, CA). For each sample, the following mix (meant for two
parallels) was prepared: 10 ll cDNA, 30 ll iQ SYBRGreen Supermix,
300 nM of each primer (MWG Biotech AG, Germany) in and nucle-
ase-free water to a ﬁnal volume of 60 ll. Aliquots of 25 ll were distrib-
uted in two wells on the PCR plate. Real-time PCR reactions were run
on an iCycler (Bio-Rad) with the following ampliﬁcation protocol:
3 min initial denaturation at 95 C, 50 cycles of 10 s denaturation at
95 C and 35 s annealing/extension at 60 C. A ﬁnal melt curve analysis
was included to verify that one speciﬁc product was obtained in each
reaction.
The fold changes in the relative gene expression were calculated
using the Gene Expression Macro, version 1.1 (Bio-Rad). Calculations
were based on the DDCt method, in which the threshold cycle number
(Ct) for each studied gene in each sample were normalised to the Ct-
value of the reference gene in the same sample. As a reference gene,
we used human acidicribosomal phosphoprotein P0 (RPLPO), which
was not aﬀected by the photochemical treatment. The normalized val-
ues (DCt) in the control sample were given a value of 1, and the fold-
change (DDCt) between the photochemically treated samples and the
controls were calculated accordingly.
L. Prasmickaite et al. / FEBS Letters 580 (2006) 5739–5746 57413. Results and discussion
To reveal the inﬂuence of a PCI-relevant photochemical
treatment on gene expression, the cells were treated with the
photosensitizer TPPS2a followed by illumination. A photo-
chemical dose corresponding to LD50 was employed, based
on previous studies demonstrating this dose to lead to an opti-
mal PCI eﬀect on transgene expression [21] and to modulate
cellular responses, i.e. induce stress-response [14]. A time point
– 3 h post-treatment – was chosen for the microarray experi-
ments, based on the assumption that this is suﬃcient for the
liberated transgenes to reach the nucleus. Therefore, character-
isation of the transcriptome at this time point was expected to
reveal the changes that could be directly implicated in tran-
scription of these transgenes. It has been reported by others
that nuclear localisation of a foreign gene may be observed
as early as 1 h post-treatment (for adenoviral vectors and
one lipidic vector [22]), though usually nuclear transport is a
slower, time-dependent process, especially for nonviral systems
[23]. Moreover, nuclear transport of a transgene after PCI can
be slowed down due to e.g. photochemical eﬀects on a cell cy-
cle [24]. Therefore, we assumed that 3 h represented the earliest
relevant time point for screening of PCI inducible promoters,
and for identiﬁcation of modulated genes with transcription-
associated functions.
We used the WiDr cell line that has already been used for
PCI-studies, both in gene – [7–9,14], protein – [4] and chemo-
therapy [3] studies, demonstrating eﬃcient responses to PCI.
Moreover, PCI in WiDr cells resulted in: (i) a lower-than-
expected eﬀect employing a promoter from the stress-response
family HSP70 [14] and ii) a higher eﬀect at the mRNA than at
the protein level of a photochemically internalised transgene
driven by the CMV promoter, indicating a PCI inﬂuence on
cellular transcription/translation on a general basis [9]. There-
fore, to understand the molecular basis behind these observa-
tions, it was of importance to characterise the response to
photochemical treatment in these cells.Fig. 1. Changes in gene expression in WiDr cells exposed to the PCI-
relevant photochemical treatment. Diﬀerentially expressed genes were
identiﬁed by one-class SAM with an estimated <5% of FDR (90
percentile). The analysis was based on the data from three biological
experiments and four hybridizations (including one dye-swap). The
diagram illustrates the results of hierarchical clustering, showing a
subset of genes that are suppressed and induced. The gene symbols of
some obviously down- and up-regulated genes are presented as an
illustration. Horizontal rows represent genes, and columns represent
the arrays corresponding to the number of the experiments. The fold-
changes of expression (presented on the log2-based scale) are color
coded as shown in the bar above, and grey elements represent missing/
quality ﬁltered values.3.1. Characterisation of photochemically induced changes in
gene expression
To identify genes with signiﬁcantly modulated expression in
photochemically treated cells compared to the control cells, we
used the one-class SAM method that assigns a score to each
gene on the basis of change in gene expression relative to the
S.D. of repeated measurements [19]. SAM uses permutations
of the repeated measurements to estimate the percentage of
genes identiﬁed by chance, i.e. the false discovery rate
(FDR). In our study, SAM identiﬁed 390 signiﬁcantly modu-
lated genes that changed at least 1.4-fold with an estimated
FDR of less than 5% (here FDR is reported as FDR90% (per-
centile), i.e. we claim with 90% conﬁdence that there are no
more then 5% of false discovered genes in the signiﬁcantly
modulated gene list). The identiﬁed genes were clustered by
hierarchical clustering, sorting the genes based on similar tran-
scriptional changes (Fig. 1). As can be seen, the up-regulated
genes dominated, constituting 88.5% of the modulated genes.
Importantly, the dye-swap experiment was clustered with the
non-swapped experiments (Fig. 1), indicating that the results
represent biological and not methodological variations.
Usually, the level of gene transcription reﬂects the activity of
the corresponding promoters [25]. A corollary to this is thatthe up-regulated genes indicate which promoters that are
photochemically induced and may be combined with PCI
for transcriptional targeting. The cluster of up-regulated
genes comprised, among others, a group of stress-response
genes from the HSP-family, like HSPA1L (HSP70-HOM),
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sponding well to the general notion that PDT induces HSPs
[15]. Among other stress-related genes in the up-regulated gene
cluster was a 3-fold up-regulated group of metallothioneins
(MT) (e.g. MT1X and MT1H) that, like HSPs, are induced
in response to stress, e.g. oxidative stress, for cellular protec-
tion [26].
Conversely, down-regulated genes should reveal promoters
that would not be optimal in combination with PCI. The clus-
ter of down-regulated genes included, among others, the gene
encoding the early growth response 1 (EGR-1) transcription
factor that is known to be signiﬁcantly up-regulated by ionis-
ing radiation [27].
Of interest, genes that inhibit transcription, e.g. inhibitor of
DNA binding ID2 or transcription factor JUNB (which antag-
onises the potent transcriptional activator JUN) appeared in
the cluster of down-regulated genes, suggesting that the photo-
chemical treatment itself does not hamper the general tran-
scriptional activity of a cell.
3.2. Functional classiﬁcation
The diﬀerentially expressed genes were also classiﬁed based
on the cellular functions involving these genes. Such classiﬁca-Table 1
Enriched Functional Categories and KEGG pathways in the list of
diﬀerentially expressed genesa
Termb Count %c P-Value
UniProt Knowledgebase
Nuclear protein 95 24.4 0.016
Metal-binding 67 17.2 0.037
DNA-binding 59 15.1 0.000056
Transcription regulation 58 14.9 0.00035
Transcription 56 14.4 0.0014
Zinc 55 14.1 0.021
Activator 22 5.6 0.0038
Cell cycle 17 4.4 0.056
Proto-oncogene 14 3.6 0.028
Ank repeat 11 2.8 0.017
Protein phosphatase 8 2.1 0.098
Methylation 6 1.5 0.047
Heat shock 5 1.3 0.0073
Copper 5 1.3 0.057
Metal-thiolate cluster 5 1.3 0.000024
Cadmium 5 1.3 0.000024
Steroid biosynthesis 5 1.3 0.019
KEGG_pathway
MAPK signaling 17 4.4 0.018
WNT signaling 12 3.1 0.025
TGF-b signaling 8 2.1 0.045
T cell receptor signaling 8 2.1 0.049
Adherens junction 8 2.1 0.023
Biosynthesis of steroids 4 1.0 0.018
Terpenoid biosynthesis 3 0.8 0.021
aGenes with signiﬁcantly changed expression following the PCI-rele-
vant photochemical treatment were identiﬁed by the SAM analysis
with an estimated FDR of less than 5% (90 percentile, i.e. 90% con-
ﬁdence that there are no more then 5% of false discovered genes in the
signiﬁcantly modulated gene list).
bFunctional classiﬁcation was based on UniProt Knowledgebase
keywords and KEGG pathway Database.
cThe gene-enrichment of functional categories was measured by
determining the number of genes belonging to the functional group in
the list of modulated genes, weighed against the total number of
analysed genes on arrays (background) using the Fisher Exact test.tion indicates the cellular functions that are likely to be aﬀected
in the cells exposed to PCI. Annotations for functional catego-
ries were found for 91% (UniProt Knowledgebase keywords)
and 28% (KEGG Pathways database) of the modulated genes.
Table 1 presents the functional groups and pathways that, as
the diﬀerentially expressed genes indicate, were aﬀected in
the photochemically treated cells. As can be seen, the genes
associated with nuclear proteins and transcription, transcrip-
tion regulation and DNA binding functions were signiﬁcantly
represented (P < 0.05) in the list of diﬀerentially expressed
genes. This suggests that the processes occurring in the nucleus
and related to transcription are aﬀected in cells exposed to the
PCI-relevant photochemical treatment. This means that tran-
scription of a foreign gene, internalised via PCI, may well be
aﬀected by the photochemical inﬂuence on the cell’s transcrip-
tional apparatus.
Besides the genes directly associated with transcription, we
identiﬁed that 4% (P = 0.056) of the aﬀected genes could be
associated with cell cycle functions. Photochemical modulation
of cell cycling might indirectly inﬂuence the expression of a for-
eign gene, especially delivered by nonviral vectors, since its
transport to the nucleus requires transition through mitosis
[28]. On the other hand, expression of a foreign gene delivered
by adenovirus and PCI might be not dependent on the cell cy-
cling, since transgene-adenovirus nuclear transport is indepen-
dent from the mitotic events [28].
Table 1 also reveals the photochemical inﬂuence on several
signalling pathways like TGF-b, MAPK and WNT. Regula-
tion of signalling pathways might have broad consequences
for various cellular functions that might inﬂuence activities
of the internalised macromolecules, and these issues remain
to be elucidated.
Supplementary Table 2 extends the information presented in
Table 1 and speciﬁes the genes from the particular functional
categories and presents fold-changes for these genes. A number
of genes encoding transcription factors were identiﬁed, includ-
ing activating protein-1 (AP-1) transcription factors (mostly
up-regulated), as well as genes (up-regulated) related to the
Nuclear Factor jB (NF-jB) pathway (see Supplementary
Table 3). This is in agreement with Luna et al. [29] and Piette
et al. [30], who demonstrated PDT-mediated induction of AP-1
(Jun, Fos) and NF-jB, respectively. Activation of AP-1 and
NF-jB might trigger transcription from the promoters carry-
ing the binding sites for these transcription factors. In this
respect, one might consider the stimulation of transcription
from the well-known CMV promoter, generally considered
as non-inducible and employed in the majority of the PCI-
based gene therapy studies [7–10,14]. The CMV promoter
has AP-1 and NF-jB binding sites, and it has been shown be-
fore that AP-1 and NF-jB are involved in CMV stimulation
[31]. Thus, the microarray-based data strengthen the theoreti-
cal possibility that PCI might also inﬂuence transcription from
the CMV promoter. This possibility has been supported by the
demonstration of a 2-fold photochemical stimulation of the
genome-integrated transgene controlled by the CMV promoter
in WiDr cells (Prasmickaite, unpublished results). This is also
in line with the data of Engesæter et al. [9], who showed that
the PCI eﬀect on CMV-controlled transgene expression is pro-
nounced more at the mRNA than at the protein level, suggest-
ing potentiated transcription, or enhanced stability of mRNA.
However, it should be stressed that Engesæter et al. [9] clearly
demonstrated that PCI aﬀects mainly the endocytic vesicles,
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promoter could be relatively moderate. Nevertheless, photo-
chemical stimulation of transcription from the CMV promoter
would strengthen the concept of exploiting PCI as a switch for
transcriptional targeting employing appropriate promoters.
An interesting ﬁnding is the signiﬁcant up-regulation of the
metal-thiolate functional category, comprising diﬀerent metal-
lothioneins (Supplementary Table 2). The photochemical inﬂu-
ence on the MT genes/promoters has so far not been well
characterised, although the oxidative-stress mediated induc-
tion of MTs has been reported [26]. One may speculate that
over-expression of MTs that act as antioxidant agents can
scavenge the reactive oxygen species and might have conse-
quences for the progression of photochemical reactions, and
consequently for the eﬀectiveness of PDT. On the other hand,
photochemically stimulated MT promoters might ﬁnd an
application for transcriptional targeting via PCI. The employ-
ment of the MT promoter for controlling transgene expression
in response to electric ﬁelds has already been demonstrated
in vivo [32], indicating the potential for MT promoter-based
regulated gene expression systems.
3.3. Photochemical eﬀect on HSP family genes
The heat shock functional category, including the HSP genes
(Supplementary Table 2), was analysed in more detail asTable 2
The heat shock protein (HSP) family genes analysed on arrays
Gene group/gene name Gen
HSP genes Hsp100
Heat shock 105 kDa/110 kDa protein 1 HS
Heat shock 70 kDa protein 4 HS
Hsp 90
TNF receptor-associated protein 1 TR
Hsp70
Heat shock 70 kDa protein 1-like HS
Stress-induced-phosphoprotein 1 (Hsp70/Hsp90-organizing prot.) STI
Heat shock 70 kDa protein 8 HS
Heat shock 70 kDa protein 1A HS
Heat shock 70 kDa protein 1B HS
Heat shock 70 kDa protein 9B (mortalin-2) HS
Heat shock 70 kDa protein 12A HS
Heat shock 70 kDa protein 14 HS
Hsp 40
Serine (or cysteine) proteinase inhibitor, clade H
(heat shock protein 47), member 1, (collagen binding protein 1)
SER
DnaJ (Hsp40) homolog, subfamily A, member 1 DN
DnaJ (Hsp40) homolog, subfamily B, member 9 DN
Small Hsp
Heat shock 22 kDa protein 8 HS
Heat shock protein, alpha-crystallin-related, B6 HS
HSPB (heat shock 27 kDa) associated protein 1 HS
Heat shock 27 kDa protein 2 HS
Other related to Hsp
Heat shock factor binding protein 1 HS
Heat shock transcription factor 2 HS
Hsp70-interacting protein HS
aFold change determined by signal intensity in photochemically treated sa
presented as the mean ± S.D. of four parallel experiments. Arrows indicate
bThe results have not been conﬁrmed by real-time PCR, which indicated a sshown in Table 2. Characterisation of the photochemical eﬀect
on these genes might be of interest for cancer therapy, and spe-
ciﬁcally for gene therapy and PDT, for several reasons: (i) the
possible use of the HSP promoters for transcriptional targeting
when combined with the cancer targeting method PCI [14]; (ii)
HSPs role in tumorigenesis, and in resistance to senescence/
apoptosis [33,34]. As can be seen, many HSP genes were pho-
tochemically induced, though at diﬀerent levels. HSP70-HOM
was identiﬁed by the microarray analysis as the most highly
induced (8-fold). However, it should be emphasized that
the real-time PCR data (Fig. 2) identiﬁed another HSP70 gene,
HSPA1B (HSP70-2), as the most up-regulated (up to 32-fold),
contradicting the microarray data. HSP70-2, -1 and -HOM are
highly homologous genes, forming HSP70 (the major HSP),
although their response to stress might diﬀer. It has been
shown that nearly identical HSP70-1 and -2, often collectively
referred to as HSP70i, contains the Heat Shock Element (HSE)
in their promoter and, therefore is considered the major stress
inducible HSP70. HSP70-HOM contains the cAMP Respon-
sive Element (CRE), but lacks HSE and, hence, generally is
non-inducible [35], although it responded to the photochemical
treatment as shown in Table 2 and Fig. 2. Identiﬁcation of the
transcription factors and the regulatory elements responsible
for the photochemical activation of a promoter will be an
important task for future research.e symbol Aliases Locus link Fold changea
PH1 HSP105A 10808 ›1.7 ± 0.2
PA4 APG-2 3308 1.3 ± 0.1
AP1 HSP75 10131 0.9 ± 0.1
PA1L HSP70-HOM 3305 ›››8.2 ± 2.2
P1 HOP 10963 ›1.7 ± 0.2
PA8 HSC70 3312 ›1.6 ± 0.1
PA1A HSP70-1 3303 1.2 ± 0.3b
PA1B HSP70-2 3304 1.4 ± 0.0b
PA9B GRP75 3313 1.4 ± 0.0
PA12A 259217 1.1 ± 0.1
PA14 HSP70-4 51182 0.9 ± 0.1
PINH1 HSP47 871 ››3.3 ± 0.9
AJA1 3301 ››2.7 ± 0.3
AJB9 4189 ››2.3 ± 0.3
PB8 HSP22 26353 ›››5.0 ± 1.5
PB6 Hsp20 126393 1.0 ± 0.3
PBAP1 79663 1.3 ± 0.2
PB2 HSP27 3316 1.1 ± 0.1
BP1 3281 1.0 ± 0.1
F2 3298 1.3 ± 0.3
PBP1 23640 1.0 ± 0.2
mples divided by signal intensity in control samples. Fold change is
signiﬁcant fold-changes.
igniﬁcant up-regulation (see Fig. 2).
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Fig. 2. Real-time PCR-based validation of the photochemical eﬀect on gene expression in WiDr cells exposed to the PCI-relevant photochemical
treatment. Six selected genes – HSPA1B (HSP70-2), HSPA1L (HSP70-HOM), SERPINH1 (HSP47), GDF15, ATF4 and EGR-1 – were assessed for
expression at mRNA level at 2 h, 4 h and 10 h after photochemical treatment by real-time PCR, using the housekeeping RPLPO gene as a reference
gene. The fold change in gene expression in photochemically treated samples compared to non-treated controls was calculated and presented as the
mean ± S.D. of three real-time PCR runs performed in duplicates. The fold-changes obtained by the microarray analysis (black-bars) are presented
for comparison.
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by real-time PCR
To verify the photochemical eﬀect on expression of genes
identiﬁed by the microarray analysis, real-time PCR was per-
formed on RNA samples prepared at 2 h, 4 h and 10 h after
PCI treatment. The diﬀerent time points were chosen for
real-time PCR to cover the 3 h time-point used for microarrays
and, at the same time, to evaluate the earlier and the later pho-
tochemical eﬀects on the selected genes. It is generally accepted
that real-time PCR provides a relatively reliable and method-
ologically independent measurement, and thus additional
information regarding the photochemical eﬀect on gene
expression initially characterised by microarrays.
The following genes were selected for validation of the
photochemical inﬂuence: the signiﬁcantly up-regulated genes
like HSP70-HOM, HSP47, GDF15, ATF4; the signiﬁcantly
down-regulated EGR-1; and the insigniﬁcantly aﬀected (1.4-
fold up-regulation) HSP70-2. The real-time PCR data generally
agreed with the microarray data, demonstrating comparable
levels of photochemical stimulation/repression of selected genes
(Fig. 2). The only exception was the HSP70-2 gene (Fig. 2),
which was the most up-regulated according to the real-time
PCR data (using two diﬀerent primer sets). This up-regulation
corresponds well to our earlier published Northern blot data
indicating photochemical induction of HSP70i [14]. Taken to-
gether, we conclude that the HSP promoters, particularly
HSP70, respond to our photochemical treatment, resulting in
enhanced transcription of the corresponding HSP genes.It should be noted that the level of photochemical stimula-
tion of the HSP-family genes/promoters depended on the
time-point after treatment (Fig. 2). The 4 h-time point led to
the highest HSP up-regulation among the three time points
tested by real-time PCR, and 10 h showed reduced up-regula-
tion. This suggests that success of transcriptional targeting via
PCI might depend on the overlap-in-time of two events: the
photochemical stimulation of the employed promoter and
the transgenes nuclear localisation (i.e. ‘‘readiness’’ for tran-
scription). One may expect that the optimal promoter for tran-
scriptional targeting via PCI would be the one that is
stimulated at the right moment, and not necessarily the one
that is stimulated the most. So far, no studies have been per-
formed to reveal these issues. The lack of such overlap could
be one of the reasons for a lower-than-expected eﬀect in the
previous study employing one of the HSP70 promoters in com-
bination with PCI [14]. However, another reason could be that
the rat HSP70.1 promoter employed in that study [14] did not
respond in the same way as the human HSP70-2 identiﬁed in
the present study.
Real-time PCR data also conﬁrmed the signiﬁcant and pro-
longed down-regulation of EGR-1 (Fig. 2). Thus, both the
microarray- and the PCR-data suggest that the EGR-1 pro-
moter does not seem to be appropriate for combination with
PCI for driving expression of an internalised transgene.
EGR-1 induction via stimulation of the promoter in response
to ionising radiation is a well-known phenomenon, and the
EGR-1 promoter has been successfully employed in gene ther-
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therapy [27]. The PDT inﬂuence on EGR-1 has already been
studied by others employing another photosensitizer [29],
and it has been demonstrated a rapid induction of EGR-1 fol-
lowing PDT, although EGR-1 mRNA decayed rapidly (within
1.5 h), indicating a very short-lasting photochemical induction.
We also conﬁrmed the up-regulation of the activating tran-
scription factor 4 (ATF4) (Fig. 2), which mediates recovery
from the stress-induced shut-oﬀ of translation [36]. Induction
of ATF4 might imply a temporal inhibition of the translational
machinery of a cell after PCI. This would be in line with
Engesæters data, showing the lower PCI eﬀect at the protein
than at the mRNA level of the internalised transgene [9]. In
this respect, PCI of PNA or siRNA, that do not need the trans-
lation step to perform a therapeutic function, should lead to
higher therapeutic improvements via PCI.
3.5. Conclusion
This study is the ﬁrst attempt to characterise transcriptomic
changes induced by photochemical treatment as used in PCI,
with the aim to extend our knowledge regarding the PCI
mechanisms of action, particularly in respect to transcriptional
targeting. Understanding of the photochemical eﬀect on
expression of genes, like the ones associated with the transcrip-
tion/translation functions, might help to foresee how the pho-
tochemically internalised transgene (as a plasmid or in an
adenoviral genome) will be processed. Consequently, this
information might be employed for the design of new PCI-
based gene therapy approaches, such as through stimulation
of promoters and transcription via the PCI stimulus. Further
development of the PCI-based targeting should include the
application of alternative promoters, for example the ones
from the HSP and the MT gene families, and cellular mecha-
nisms related to PCI-induced cellular response, as demon-
strated by the information gained through the microarray
analysis.
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